L866-1329 Screening compound: N-benzyl-3-(4-{[(3,4-difluorophenyl)carbamoyl]methyl}-3-oxo-3,4-dihydroquinoxalin-2-yl)propanamide

L866-1329 Screening compound: N-benzyl-3-(4-{[(3,4-difluorophenyl)carbamoyl]methyl}-3-oxo-3,4-dihydroquinoxalin-2-yl)propanamide
L866-1329 Screening compound: N-benzyl-3-(4-{[(3,4-difluorophenyl)carbamoyl]methyl}-3-oxo-3,4-dihydroquinoxalin-2-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L866-1329
N-benzyl-3-(4-{[(3,4-difluorophenyl)carbamoyl]methyl}-3-oxo-3,4-dihydroquinoxalin-2-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L866-1329

Molecular Formula

C26H22F2N4O3 (C26 H22 F2 N4 O3)

Compound Name

N-benzyl-3-(4-{[(3,4-difluorophenyl)carbamoyl]methyl}-3-oxo-3,4-dihydroquinoxalin-2-yl)propanamide

IUPAC name

N-benzyl-3-(4-{[(34-difluorophenyl)carbamoyl]methyl}-3-oxo-34-dihydroquinoxalin-2-yl)propanamide

SMILES

O=C(CCC1=Nc(cccc2)c2N(CC(Nc(cc2)cc(F)c2F)=O)C1=O)NCc1ccccc1

InChI

InChI=1S/C26H22F2N4O3/c27-19-11-10-18(14-20(19)28)30-25(34)16-32-23-9-5-4-8-21(23)31-22(26(32)35)12-13-24(33)29-15-17-6-2-1-3-7-17/h1-11,14H,12-13,15-16H2,(H,29,33)(H,30,34)

InChI Key

HPNWIPKYQGGWPA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27482891

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.325

Distribution Coefficient, logD

3.314

Water Solubility, LogSw

-3.62

Polar Surface Area

70.703

Acid Dissociation Constant (pKa)

9.01

Base Dissociation Constant (pKb)

1.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.40

L866-1329 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L866-1329 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L866-1329?
Check Price and Availability of L866-1329, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L866-1329 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L866-1329
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L866-1329
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L866-1329 available by request